Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas, George D
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). [electronic resource] - JACC. Cardiovascular interventions Sep 2013 - 914-22 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
1876-7605
10.1016/j.jcin.2013.05.005 doi
Aged
Cardiovascular Agents--administration & dosage
Coronary Artery Disease--diagnosis
Coronary Restenosis--etiology
Coronary Thrombosis--etiology
Drug-Eluting Stents
Everolimus
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Myocardial Infarction--etiology
Paclitaxel--administration & dosage
Percutaneous Coronary Intervention--adverse effects
Proportional Hazards Models
Prosthesis Design
Randomized Controlled Trials as Topic
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome
Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). [electronic resource] - JACC. Cardiovascular interventions Sep 2013 - 914-22 p. digital
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
1876-7605
10.1016/j.jcin.2013.05.005 doi
Aged
Cardiovascular Agents--administration & dosage
Coronary Artery Disease--diagnosis
Coronary Restenosis--etiology
Coronary Thrombosis--etiology
Drug-Eluting Stents
Everolimus
Female
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Multicenter Studies as Topic
Multivariate Analysis
Myocardial Infarction--etiology
Paclitaxel--administration & dosage
Percutaneous Coronary Intervention--adverse effects
Proportional Hazards Models
Prosthesis Design
Randomized Controlled Trials as Topic
Risk Factors
Sirolimus--administration & dosage
Time Factors
Treatment Outcome